Inventor
PATEL MONA
US24 patents
⚠️ This page may combine multiple inventors who share the name “PATEL MONA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
11 patentsUS7511022B2Mar 31, 2009
Substituted indole-O-glucosides
JANSSEN PHARMACEUTICA NV27 citations92
US7129220B2Oct 31, 2006
Substituted indole-O-glucosides
JANSSEN PHARMACEUTICA NV13 citations83
US7084124B2Aug 1, 2006
Substituted indazole-O-glucosides
JANSSEN PHARMACEUTICA NV9 citations73
US7511021B2Mar 31, 2009
Substituted indazole-O-glucosides
JANSSEN PHARMACEUTICA NV3 citations62
US7531671B2May 12, 2009
Dihydroisoindolones as allosteric modulators of glucokinase
JANSSEN PHARMACEUTICA NV2 citations58
US7820630B2Oct 26, 2010
Substituted indole-O-glucosides
JANSSEN PHARMACEUTICA NV0 citations51
US7816331B2Oct 19, 2010
Substituted indazole-O-glucosides
JANSSEN PHARMACEUTICA NV0 citations51
US7825110B2Nov 2, 2010
Substituted spiroheterocycles
JANSSEN PHARMACEUTICA NV1 citations49
US7928246B2Apr 19, 2011
Dihydroisoindolones as allosteric modulators of glucokinase
JANSSEN PHARMACEUTICA NV0 citations47
US7687494B2Mar 30, 2010
Substituted spirobenzazepines
JANSSEN PHARMACEUTICA NV1 citations46
US7825111B2Nov 2, 2010
Substituted spiroheterocycles
JANSSEN PHARMACEUTICA NV0 citations38
DU PONT PHARM CO
4 patentsUS5874430AFeb 23, 1999
4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
DU PONT PHARM CO87 citations89
US6265406B1Jul 24, 2001
Substituted quinolin-2 (1H) -ones useful as HIV reverse transcriptase inhibitors
DU PONT PHARM CO3 citations63
US6225317B1May 1, 2001
Crystalline (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinone
DU PONT PHARM CO5 citations59
US6303780B1Oct 16, 2001
4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
DU PONT PHARM CO0 citations49
PATEL MONA
2 patentsBRISTOL MYERS SQUIBB PHARMA CO
2 patentsUS6593337B1Jul 15, 2003
Tricyclic compounds useful as HIV reverse transcriptase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO3 citations62
US6492515B2Dec 10, 2002
4,4-disubstituted-1, 4-dihydro-2H-3, 1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
BRISTOL MYERS SQUIBB PHARMA CO1 citations60